{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:01:18Z","timestamp":1765886478504,"version":"3.32.0"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes for Health Research","doi-asserted-by":"crossref","award":["PJT-153429, PJT-156306, and HEV-172884"],"award-info":[{"award-number":["PJT-153429, PJT-156306, and HEV-172884"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008360","name":"Hamilton Health Sciences","doi-asserted-by":"publisher","award":["HAH-16-04"],"award-info":[{"award-number":["HAH-16-04"]}],"id":[{"id":"10.13039\/100008360","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Individuals with opioid use disorder (OUD) have a high prevalence of co-occurring mental health disorders; however, there exists little information on mental health service use for this population. We aimed to determine the prevalence of non-substance use-related mental health emergency department (ED) visits, hospitalizations, and outpatient physician visits for individuals receiving treatment for OUD over one year. We also explored individual-level characteristics associated with mental health care service use and estimated the costs of this care.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>We linked observational cohort data collected from 3,430 individuals receiving treatment for OUD in Ontario, Canada, with health administrative records available for all individuals enrolled in Ontario\u2019s public health insurance program. Eligible participants were receiving medication treatment for OUD and were recruited between 2011 and 2021 Starting on the day of cohort enrolment, we included health service data for up to 12 months. We identified ED visits and hospitalizations for non-substance use-related mental health disorders using ICD-10-CA diagnostic codes. Outpatient mental health visits to primary care providers and psychiatrists were ascertained by examining the diagnostic codes of physician billing claims. We used logistic regression to explore the association between demographic and clinical factors of interest and mental health-related ED visits or hospitalizations. Mean one-year mental healthcare costs, calculated in 2022 Canadian dollars, were estimated. We fit a two-part zero-inflated negative binomial model to explore the association between factors of interest and healthcare costs.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Findings<\/jats:title>\n<jats:p>Altogether, 14.9% of individuals had mental health-related acute care ED visits or hospitalizations and 37.3% had outpatient mental health visits during the follow up period. For participants with at least one visit, we determined the mean number of ED visits (1.93, standard deviation [SD] = 2.15), hospitalizations (1.46, SD = 1.05), primary care visits (3.51, SD = 4.31), and psychiatry visits (4.04, SD = 4.73). Lower odds of ED use and hospitalization were associated with older age (46+ compared to less than 25 years: odds ratio [OR] 0.43, 95% confidence interval [CI]: 0.29, 0.63) and being employed (OR 0.48, 95% CI 0.37, 0.61). Higher odds of ED use and hospitalization was associated with positive opioid urine drug screens (50% positive urine drug screens compared to 0%: OR 1.45, 95% CI 1.05, 2.01), having more comorbid conditions (7+ health conditions compared to 0\u20132 health conditions: OR 3.76, 95% CI 2.60, 5.44), and receipt of outpatient mental healthcare (OR 2.38, 95% CI 1.95, 2.92) were associated with higher odds of ED visits or hospitalizations. Mean one-year mental healthcare costs for individuals receiving ED visits or hospitalizations totaled $9,117.80 (95% CI 7,372.90, 10,862.70) per person. Mean one-year costs for individuals with outpatient mental healthcare alone totaled $382.30 (95% CI 343.20, 421.30) per person.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Individuals receiving treatment for OUD receive care in EDs, inpatient units, and outpatient clinics for mental health conditions other than substance use-related diagnoses. Healthcare costs were considerably higher for those receiving acute care treatment for mental health conditions. Studying integrated mental health and substance use disorder treatment in the outpatient setting should be a priority to bolster care for this population.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0314296","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T19:21:47Z","timestamp":1736364107000},"page":"e0314296","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Hospital and physician-based mental healthcare during 12 months of opioid agonist treatment for opioid use disorder: Exploring costs and factors associated with acute care"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7406-4056","authenticated-orcid":true,"given":"Tea","family":"Rosic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenda","family":"Babe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myanca","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brittany B.","family":"Dennis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3595-486X","authenticated-orcid":true,"given":"Richard","family":"Perez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Worster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lehana","family":"Thabane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zainab","family":"Samaan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,1,8]]},"reference":[{"key":"pone.0314296.ref001","unstructured":"Gomes T, Murray R, Kolla G, Leece P, Kitchen S, Campbell T, et al. on behalf of the Ontario Drug Policy Research Network, Office of the Chief Coroner for Ontario and Ontario Agency for Health Protection and Promotion (Public Health Ontario). Patterns of medication and healthcare use among people who died of an opioid-related toxicity during the COVID-19 pandemic in Ontario. Toronto, ON: Ontario Drug Policy Research Network; 2022."},{"key":"pone.0314296.ref002","unstructured":"Ahmad FB, Cisewski JA, Rossen LM, Sutton P. Provisional drug overdose death counts. National Center for Health Statistics. 2023."},{"issue":"3","key":"pone.0314296.ref003","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/add.15801","article-title":"National trends in population rates of opioid-related mortality, hospitalization and emergency department visits in Canada between 2000 and 2017. A population-based study","volume":"117","author":"MW Alsabbagh","year":"2022","journal-title":"Addiction"},{"issue":"10","key":"pone.0314296.ref004","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s40261-022-01192-0","article-title":"Healthcare Utilization of Patients with Opioid Use Disorder in US Hospitals from 2016 to 2019: Focusing on Racial and Regional Variances","volume":"42","author":"SJ Kim","year":"2022","journal-title":"Clin Drug Investig"},{"issue":"11","key":"pone.0314296.ref005","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1111\/add.15963","article-title":"Association of opioid use disorder with healthcare utilization and cost in a public health system","volume":"117","author":"O Miron","year":"2022","journal-title":"Addiction"},{"issue":"4","key":"pone.0314296.ref006","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/ADM.0000000000000928","article-title":"Trends in Hospitalizations for Serious Infections Among People With Opioid Use Disorder in Ontario, Canada","volume":"16","author":"T Gomes","year":"2022","journal-title":"J Addict Med"},{"issue":"4","key":"pone.0314296.ref007","doi-asserted-by":"crossref","first-page":"e0232191","DOI":"10.1371\/journal.pone.0232191","article-title":"A retrospective cohort study evaluating correlates of deep tissue infections among patients enrolled in opioid agonist treatment using administrative data in Ontario, Canada","volume":"15","author":"KA Morin","year":"2020","journal-title":"PLoS One"},{"issue":"7","key":"pone.0314296.ref008","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1093\/cid\/ciaa008","article-title":"Bacterial Infections Associated With Substance Use Disorders, Large Cohort of United States Hospitals, 2012\u20132017","volume":"71","author":"NL McCarthy","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"6","key":"pone.0314296.ref009","doi-asserted-by":"crossref","first-page":"e012465","DOI":"10.1161\/JAHA.119.012465","article-title":"Trends in Infective Endocarditis Hospitalizations, Characteristics, and Valve Operations in Patients With Opioid Use Disorders in the United States: 2005\u20132014","volume":"9","author":"M Mori","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"pone.0314296.ref010","doi-asserted-by":"crossref","first-page":"109551","DOI":"10.1016\/j.drugalcdep.2022.109551","article-title":"Prevalence of mental disorders among people with opioid use disorder: A systematic review and meta-analysis","volume":"238","author":"T Santo","year":"2022","journal-title":"Drug Alcohol Depend"},{"key":"pone.0314296.ref011","unstructured":"Government of Canada. Opioid-related harms and mental disorders in Canada: A descriptive analysis of hospitalization data. Accessed April 18, 2023, from: https:\/\/www.canada.ca\/en\/health-canada\/services\/opioids\/data-surveillance-research\/opioid-related-hospitalizations-mental-disorders.html."},{"issue":"6","key":"pone.0314296.ref012","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/add.12860","article-title":"Long-term mortality, remission, criminality and psychiatric comorbidity of heroin dependence: 11-year findings from the Australian Treatment Outcome Study","volume":"110","author":"M Teesson","year":"2015","journal-title":"Addiction"},{"issue":"4","key":"pone.0314296.ref013","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00127-021-02199-2","article-title":"Mental disorder and opioid overdose: a systematic review","volume":"57","author":"J van Draanen","year":"2022","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"pone.0314296.ref014","doi-asserted-by":"crossref","first-page":"108267","DOI":"10.1016\/j.drugalcdep.2020.108267","article-title":"Profile and correlates of injecting-related injuries and diseases among people who inject drugs in Australia","volume":"216","author":"S Colledge","year":"2020","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"pone.0314296.ref015","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12954-020-00396-x","article-title":"A cohort study evaluating the association between concurrent mental disorders, mortality, morbidity, and continuous treatment retention for patients in opioid agonist treatment (OAT) across Ontario, Canada, using administrative health data","volume":"17","author":"KA Morin","year":"2020","journal-title":"Harm Reduct J"},{"issue":"2","key":"pone.0314296.ref016","doi-asserted-by":"crossref","first-page":"S230","DOI":"10.1016\/j.jval.2019.04.1069","article-title":"Healthcare utilization and costs associated with mental health in patients with opioid use disorders","volume":"22","author":"L Park","year":"2019","journal-title":"Value in Health"},{"issue":"4","key":"pone.0314296.ref017","doi-asserted-by":"crossref","first-page":"e138","DOI":"10.1192\/bjo.2021.971","article-title":"Trauma and post-traumatic stress disorder in patients treated for opioid use disorder: findings from a 12-month cohort study","volume":"7","author":"T Rosic","year":"2021","journal-title":"BJPsych Open"},{"issue":"10","key":"pone.0314296.ref018","doi-asserted-by":"crossref","first-page":"e1001885","DOI":"10.1371\/journal.pmed.1001885","article-title":"The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement","volume":"12","author":"EI Benchimol","year":"2015","journal-title":"PLoS Med"},{"issue":"12","key":"pone.0314296.ref019","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.013","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies","volume":"12","author":"E von Elm","year":"2014","journal-title":"Int J Surg"},{"key":"pone.0314296.ref020","unstructured":"Mental Health and Addictions Program Framework Research Team. Mental Health and Addictions System Performance in Ontario: 2021 Scorecard. Technical Appendix. Toronto, ON: ICES; 2021."},{"issue":"1","key":"pone.0314296.ref021","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1377\/hlthaff.2015.0278","article-title":"Patients With High Mental Health Costs Incur Over 30 Percent More Costs Than Other High-Cost Patients","volume":"35","author":"C de Oliveira","year":"2016","journal-title":"Health Aff (Millwood)"},{"issue":"50","key":"pone.0314296.ref022","doi-asserted-by":"crossref","first-page":"E1793","DOI":"10.1503\/cmaj.200274","article-title":"Characteristics of patients with mental illness and persistent high-cost status: a population-based analysis","volume":"192","author":"C de Oliveira","year":"2020","journal-title":"CMAJ"},{"key":"pone.0314296.ref023","unstructured":"Canadian Institute for Health Information. CIHI\u2019s Population Grouping Methodology 1.4 \u2013Overview and Outputs, 2023. Ottawa, ON: CIHI;2023."},{"key":"pone.0314296.ref024","unstructured":"Wodchis WP, Bushmeneva K, Nikitovic M, McKillop I. Guidelines on person-level costing using administrative databases in Ontario [Internet]. Toronto: Health System Performance Research Network; 2013 May [cited 2015 Nov 10]. (Working Paper Vol. 1). http:\/\/www.hsprn.ca\/uploads\/files\/Guidelines_on_PersonLevel_Costing_May_2013.pdf."},{"issue":"1","key":"pone.0314296.ref025","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1377\/hlthaff.2015.0278","article-title":"Patients with high mental health costs incur over 30 percent more costs than other high-cost patients","volume":"35","author":"C de Oliveira","year":"2016","journal-title":"Health Aff"},{"issue":"50","key":"pone.0314296.ref026","doi-asserted-by":"crossref","first-page":"E1793","DOI":"10.1503\/cmaj.200274","article-title":"Characteristics of patients with mental illness and persistent high-cost status: a population-based analysis","volume":"192","author":"C de Oliveira","year":"2020","journal-title":"CMAJ"},{"key":"pone.0314296.ref027","doi-asserted-by":"crossref","first-page":"848072","DOI":"10.3389\/frhs.2022.848072","article-title":"Health Care Expenditures Among Individuals With Chronic Psychotic Disorders in Ontario: An Analysis Over Time","volume":"2","author":"C de Oliveira","year":"2022","journal-title":"Front Health Serv"},{"key":"pone.0314296.ref028","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1503\/cmaj.150064","article-title":"A 3-year study of high-cost users of health care","volume":"188","author":"WP Wodchis","year":"2016","journal-title":"CMAJ"},{"issue":"5","key":"pone.0314296.ref029","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/bimj.4710360505","article-title":"Zero\u2010altered and other regression models for count data with added zeros","volume":"36","author":"DC Heilbron","year":"1994","journal-title":"Biometrical Journal"},{"key":"pone.0314296.ref030","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s40745-021-00328-x","article-title":"Zero-Inflated Models for Count Data: An Application to Number of Antenatal Care Service Visits","volume":"8","author":"D.B. Bekalo","year":"2021","journal-title":"Ann. Data. Sci"},{"issue":"1","key":"pone.0314296.ref031","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12874-022-01733-3","article-title":"Count data models for outpatient health services utilisation","volume":"22","author":"NS Abu Bakar","year":"2022","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"pone.0314296.ref032","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41398-021-01372-0","article-title":"Association of co-occurring opioid or other substance use disorders with increased healthcare utilization in patients with depression","volume":"11","author":"V Vekaria","year":"2021","journal-title":"Transl Psychiatry"},{"issue":"2","key":"pone.0314296.ref033","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1177\/0706743717748926","article-title":"Temporal Trends in Mental Health Service Utilization across Outpatient and Acute Care Sectors: A Population-Based Study from 2006 to 2014","volume":"63","author":"M Chiu","year":"2018","journal-title":"Can J Psychiatry"},{"issue":"4","key":"pone.0314296.ref034","doi-asserted-by":"crossref","first-page":"e215902","DOI":"10.1001\/jamanetworkopen.2021.5902","article-title":"Incidence of Access to Ambulatory Mental Health Care Prior to a Psychiatric Emergency Department Visit Among Adults in Ontario, 2010\u20132018","volume":"4","author":"P Kurdyak","year":"2021","journal-title":"JAMA Netw Open"},{"key":"pone.0314296.ref035","unstructured":"Canadian Substance Use Costs and Harms Scientific Working Group. (2020). Canadian substance use costs and harms 2015\u20132017. (Prepared by the Canadian Institute for Substance Use Research and the Canadian Centre on Substance Use and Addiction.) Ottawa, Ont.: Canadian Centre on Substance Use and Addiction."},{"issue":"15","key":"pone.0314296.ref036","doi-asserted-by":"crossref","first-page":"541","DOI":"10.15585\/mmwr.mm7015a1","article-title":"State-Level Economic Costs of Opioid Use Disorder and Fatal Opioid Overdose\u2014United States, 2017","volume":"70","author":"F Luo","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"pone.0314296.ref037","doi-asserted-by":"crossref","first-page":"E160","DOI":"10.9778\/cmajo.20220089","article-title":"The impact of poisoning in British Columbia: a cost analysis","volume":"11","author":"F Rajabali","year":"2023","journal-title":"CMAJ Open"},{"issue":"36","key":"pone.0314296.ref038","doi-asserted-by":"crossref","first-page":"E1233","DOI":"10.1503\/cmaj.220892","article-title":"Clinical outcomes and health care costs among people entering a safer opioid supply program in Ontario","volume":"194","author":"T Gomes","year":"2022","journal-title":"CMAJ"},{"key":"pone.0314296.ref039","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jsat.2018.12.006","article-title":"Behavioral health treatment utilization among individuals with co-occurring opioid use disorder and mental illness: Evidence from a national survey","volume":"98","author":"P Novak","year":"2019","journal-title":"J Subst Abuse Treat"},{"issue":"12","key":"pone.0314296.ref040","doi-asserted-by":"crossref","first-page":"e0243317","DOI":"10.1371\/journal.pone.0243317","article-title":"Evaluating the effectiveness of concurrent opioid agonist treatment and physician-based mental health services for patients with mental disorders in Ontario, Canada","volume":"15","author":"KA Morin","year":"2020","journal-title":"PLoS One"},{"issue":"2","key":"pone.0314296.ref041","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jsat.2013.07.012","article-title":"Comparing barriers to mental health treatment and substance use disorder treatment among individuals with comorbid major depression and substance use disorders","volume":"46","author":"R Mojtabai","year":"2014","journal-title":"J Subst Abuse TreatFeb"},{"issue":"3\u20134","key":"pone.0314296.ref042","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1080\/19371918.2013.774673","article-title":"Integrated treatment of substance use and psychiatric disorders","volume":"28","author":"TM Kelly","year":"2013","journal-title":"Soc Work Public Health"},{"issue":"2","key":"pone.0314296.ref043","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1001\/jamapsychiatry.2018.3123","article-title":"What Role Should Psychiatrists Have in Responding to the Opioid Epidemic?","volume":"76","author":"SB Muvvala","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"pone.0314296.ref044","volume-title":"Best Practices Across the Continuum of Care for the Treatment of Opioid Use Disorder","author":"S. Taha","year":"2018"},{"issue":"11","key":"pone.0314296.ref045","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1111\/add.12269","article-title":"Managing psychiatric comorbidity within versus outside of methadone treatment settings: a randomized and controlled evaluation","volume":"108","author":"RK Brooner","year":"2013","journal-title":"AddictionNov"},{"issue":"1","key":"pone.0314296.ref046","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.drugalcdep.2013.06.005","article-title":"Reinforcing integrated psychiatric service attendance in an opioid-agonist program: a randomized and controlled trial","volume":"133","author":"M Kidorf","year":"2013","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"pone.0314296.ref047","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13011-019-0213-6","article-title":"Concurrent psychiatry for patients enrolled in opioid agonist treatment: a propensity score matched cohort study in Ontario Canada","volume":"14","author":"KA Morin","year":"2019","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"1","key":"pone.0314296.ref048","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/add.15594","article-title":"Long-term follow-up assessment of opioid use outcomes among individuals with comorbid mental disorders and opioid use disorder treated with buprenorphine or methadone in a randomized clinical trial","volume":"117","author":"YI Hser","year":"2022","journal-title":"Addiction"},{"issue":"2","key":"pone.0314296.ref049","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/ADM.0000000000000193","article-title":"A Systematic Review on the Use of Psychosocial Interventions in Conjunction With Medications for the Treatment of Opioid Addiction","volume":"10","author":"K Dugosh","year":"2016","journal-title":"J Addict Med"},{"issue":"9","key":"pone.0314296.ref050","doi-asserted-by":"crossref","first-page":"E247","DOI":"10.1503\/cmaj.170958","article-title":"Management of opioid use disorders: a national clinical practice guideline","volume":"190","author":"J Bruneau","year":"2018","journal-title":"CMAJ"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0314296","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T19:22:04Z","timestamp":1736364124000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0314296"}},"subtitle":[],"editor":[{"given":"Lakshit","family":"Jain","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,1,8]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0314296","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,8]]}}}